Mallinckrodt Misses Bond Interest Payments as Financial Woes Worsen
Wall Street Journal
Mallinckrodt, the generic drugmaker that has struggled financially since exiting from bankruptcy last year, said it has decided not to make $56 million of interest payments due this week to holders of its secured bonds.